Deerfield, IL - Baxter International is now recalling from the market all remaining lots and doses of its heparin sodium multidose and single-dose vials for injection and its heparin lock flush ...

Review the side-effects of Preservative-Free Heparin Lock Flush Solution as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking ...

Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...

Up-to-date prescription details regarding Preservative-Free Heparin Lock Flush Solution are provided here. Understand it's uses, recommended dosages, its indications, how to take, when to take, when ...

A study published in Clinical Infectious Diseases examined the cost-effectiveness of antimicrobial locks for the prevention of central line-associated bloodstream infections. Antibiotic lock therapy ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received clearance ...

The FDA has now concluded that there is sufficient capacity on the part of other suppliers that Baxter's recall will not jeopardize access to this drug, and has told Baxter that the company can now ...

This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...

The U.S. Pharmacopeial Convention (USP) has revised its current standards on heparin labeling requirements to address safety concerns about the expression of drug strength. The labeling sections for ...

Early last Saturday, nurses at an Indianapolis hospital went to the drug cabinet in the newborn intensive care unit to get blood-thinner for several premature babies. The nurses didn't realize a ...

Ethanol locks have the ability to prevent central venous catheter-associated bloodstream infections in pediatric cancer patients, according to the results of a randomized trial published in the ...